“…Studies have demonstrated that the incidence of MF/SS in the United States is highest in populations with SOC, with prominent differences in disease presentation and outcomes between NSOC and SOC patients with MF/SS, including younger age at clinical presentation and higher mortality rates among SOC patients [1,2,5]. Previous studies have described the negative impacts that CTCL has on patients' health-related quality of life (HRQoL), which encompasses physical, psychological, and social aspects of health [6][7][8][9]. Recently, our group did a survey study that compared HRQoL between SOC and NSOC patients with CTCL and found that the degree of pruritus, skin-related embarrassment, and interference with participation in sports, social, and leisure activities were significantly more pronounced in SOC patients [8].…”